Literature DB >> 25518047

Increased ultraviolet light exposure is associated with reduced risk of inpatient surgery among patients with Crohn's disease.

Shail M Govani1, Peter D R Higgins2, Ryan W Stidham2, Scott J Montain3, Akbar K Waljee4.   

Abstract

BACKGROUND AND AIMS: Due to the formation of strictures and fistulas, patients with Crohn's disease (CD) frequently need surgery. Vitamin D has been found to play a role in the degree of inflammation. We aimed to study the effect of UV exposure on the need for inpatient surgery in patients with CD.
METHODS: The national inpatient sample, the largest database of hospitalizations from the USA, was used to conduct a retrospective study of patients hospitalized from 2004-2011 with CD by ICD-9CM code 555. Surgery was characterized as any intestinal surgery or fistula repair. An average state UV exposure was calculated for each hospitalization. Multivariate logistic regression was used to calculate the effect of UV exposure on surgery accounting for important covariates.
RESULTS: There were 481712 hospitalizations with a primary diagnosis of CD. Of these hospitalizations, 67751 included a relevant surgical procedure code. Mean UV exposure was statistically lower in the group undergoing surgery (4.3 units versus 4.4 units, p = 0.001). The ratio of hospitalizations per UV exposure tertile for CD was statistically different compared with all hospitalizations (p < 0.001). In univariate analysis, increased UV exposure was associated with a lower risk of inpatient surgery with an OR of 0.90 per unit (95% CI 0.84-0.96, p = 0.001). Accounting for age, gender, race/ethnicity, season, income, hospital setting, and Charlson-Deyo comorbidities, the effect of UV exposure remained protective for inpatient surgery (OR 0.91, 95% CI: 0.84-0.98, p = 0.01).
CONCLUSIONS: Increased UV exposure is associated with a reduced risk of inpatient surgery among patients with CD. Further studies of vitamin D's role in CD are necessary.
Copyright © 2014 European Crohn’s and Colitis Organisation (ECCO). Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Crohn’s disease; UV light; Vitamin D; surgery

Mesh:

Year:  2014        PMID: 25518047     DOI: 10.1093/ecco-jcc/jju002

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  6 in total

1.  Increasing ultraviolet light exposure is associated with reduced mortality from Clostridium difficile infection.

Authors:  Shail M Govani; Akbar K Waljee; Ryan W Stidham; Peter Dr Higgins
Journal:  United European Gastroenterol J       Date:  2015-04       Impact factor: 4.623

Review 2.  The role of UVR and vitamin D on T cells and inflammatory bowel disease.

Authors:  Stephanie Bora; Margherita T Cantorna
Journal:  Photochem Photobiol Sci       Date:  2017-03-16       Impact factor: 3.982

Review 3.  Vitamin D and inflammatory bowel disease.

Authors:  Marco Ardesia; Guido Ferlazzo; Walter Fries
Journal:  Biomed Res Int       Date:  2015-04-27       Impact factor: 3.411

Review 4.  The Role of Vitamin D in Inflammatory Bowel Disease: Mechanism to Management.

Authors:  Jane Fletcher; Sheldon C Cooper; Subrata Ghosh; Martin Hewison
Journal:  Nutrients       Date:  2019-05-07       Impact factor: 5.717

5.  Insolation and Disease Severity in Paediatric Inflammatory Bowel Disease-A Multi-Centre Cross-Sectional Study.

Authors:  Aleksandra Glapa-Nowak; Mariusz Szczepanik; Jarosław Kwiecień; Anna Szaflarska-Popławska; Anna Flak-Wancerz; Barbara Iwańczak; Marcin Osiecki; Jarosław Kierkuś; Tomasz Pytrus; Dariusz Lebensztejn; Tomasz Banasiewicz; Aleksandra Banaszkiewicz; Jarosław Walkowiak
Journal:  J Clin Med       Date:  2020-12-07       Impact factor: 4.241

6.  Northern Latitude but Not Season Is Associated with Increased Rates of Hospitalizations Related to Inflammatory Bowel Disease: Results of a Multi-Year Analysis of a National Cohort.

Authors:  Adam C Stein; John Nick Gaetano; Jeffrey Jacobs; Rangesh Kunnavakkam; Marc Bissonnette; Joel Pekow
Journal:  PLoS One       Date:  2016-08-31       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.